RTTNews | Jan 28, 2022 08:49AM EST

08:49 Friday, January 28, 2022 (RTTNews.com) - Merck's Molnupiravir, COVID-19 Medicine, Shows Activity Against Omicron Variant In Vitro Studies

For comments and feedback: contact editorial@rttnews.com

https://www.rttnews.comCopyright(c) 2022 RTTNews.com All Rights Reserved